Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
The Journal of Clinical Psychiatry
|
January 20, 2006
Efficacy of aripiprazole against hostility in schizophrenia and schizoaffective disorder: data from 5 double-blind studies
Jan Volavka, Pal Czobor, Leslie Citrome, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
July 2, 2008
A randomized, double-blind, placebo-controlled study of aripiprazole for the treatment of psychosis in nursing home patients with Alzheimer disease
Joel E Streim, Anton P Porsteinsson, Christopher D Breder, et al.
International Journal of Psychiatry in Clinical Practice
|
February 3, 2012
Aripiprazole in bipolar depression: a pooled, post-hoc analysis by severity of core depressive symptoms
Michael E Thase, Charles L Bowden, Michael Nashat, et al.
Bipolar Disorders
|
February 15, 2012
Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392)
Berit X Carlson, Terence A Ketter, Wei Sun, et al.
Postgraduate Medicine
|
January 26, 2019
A proposed anti-maladaptive aggression agent classification: improving our approach to treating impulsive aggression
Adelaide S Robb, Stefan Schwabe, Gianpiera Ceresoli-Borroni, et al.
Joint Commission Journal on Quality and Patient Safety
|
January 19, 2008
John M. Eisenberg Patient Safety and Quality Awards. Impact of CRM-based training on obstetric outcomes and clinicians' patient safety attitudes
Stephen D Pratt, Susan Mann, Mary Salisbury, et al.
The Primary Care Companion for CNS Disorders
|
July 7, 2011
Safety and tolerability of aripiprazole in the treatment of irritability associated with autistic disorder in pediatric subjects (6-17 years old):results from a pooled analysis of 2 studies
Adelaide S Robb, Candace Andersson, Elizabeth E Bellocchio, et al.
Schizophrenia Research
|
May 6, 2003
Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials
Stephen R Marder, Robert D McQuade, Elyse Stock, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
September 2, 2005
Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial
Eduard Vieta, Michel Bourin, Raymond Sanchez, et al.
The American Journal of Psychiatry
|
February 4, 2026
Long-Term Safety and Efficacy of Xanomeline and Trospium Chloride in Schizophrenia: A 52-Week Open-Label Extension Trial
Inder Kaul, Amy Claxton, Colin Sauder, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
The Journal of Clinical Psychiatry
|
January 20, 2006
Efficacy of aripiprazole against hostility in schizophrenia and schizoaffective disorder: data from 5 double-blind studies
Jan Volavka, Pal Czobor, Leslie Citrome, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
July 2, 2008
A randomized, double-blind, placebo-controlled study of aripiprazole for the treatment of psychosis in nursing home patients with Alzheimer disease
Joel E Streim, Anton P Porsteinsson, Christopher D Breder, et al.
International Journal of Psychiatry in Clinical Practice
|
February 3, 2012
Aripiprazole in bipolar depression: a pooled, post-hoc analysis by severity of core depressive symptoms
Michael E Thase, Charles L Bowden, Michael Nashat, et al.
Bipolar Disorders
|
February 15, 2012
Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392)
Berit X Carlson, Terence A Ketter, Wei Sun, et al.
Postgraduate Medicine
|
January 26, 2019
A proposed anti-maladaptive aggression agent classification: improving our approach to treating impulsive aggression
Adelaide S Robb, Stefan Schwabe, Gianpiera Ceresoli-Borroni, et al.
Joint Commission Journal on Quality and Patient Safety
|
January 19, 2008
John M. Eisenberg Patient Safety and Quality Awards. Impact of CRM-based training on obstetric outcomes and clinicians' patient safety attitudes
Stephen D Pratt, Susan Mann, Mary Salisbury, et al.
The Primary Care Companion for CNS Disorders
|
July 7, 2011
Safety and tolerability of aripiprazole in the treatment of irritability associated with autistic disorder in pediatric subjects (6-17 years old):results from a pooled analysis of 2 studies
Adelaide S Robb, Candace Andersson, Elizabeth E Bellocchio, et al.
Schizophrenia Research
|
May 6, 2003
Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials
Stephen R Marder, Robert D McQuade, Elyse Stock, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
September 2, 2005
Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial
Eduard Vieta, Michel Bourin, Raymond Sanchez, et al.
The American Journal of Psychiatry
|
February 4, 2026
Long-Term Safety and Efficacy of Xanomeline and Trospium Chloride in Schizophrenia: A 52-Week Open-Label Extension Trial
Inder Kaul, Amy Claxton, Colin Sauder, et al.
Page
of 3